Michaéla C Schippers, Kasper P Kepp, John P A Ioannidis
{"title":"Biases and debiasing in policy decision-making.","authors":"Michaéla C Schippers, Kasper P Kepp, John P A Ioannidis","doi":"10.1111/eci.70064","DOIUrl":null,"url":null,"abstract":"<p><p>Policy decision-making should use the best evidence obtained with the most rigorous and reproducible science and should be applied with minimal bias to maximize positive outcomes. This is particularly important in public health and other major decisions. Reality, however, is usually far from this ideal. The quality and use of scientific evidence to address wicked problems and sticky crises have been the focus of intense debate. Policymakers often succumb to fallacies, leading to suboptimal decision-making and maladaptive practices. We map the key biases involved at three different, but communicating, domains: the scientific evidence itself, the policymakers and the citizens. Biases may be classified along two axes pertaining to the perception of the risk and the perception of the effectiveness of the intervention: minimizing risk (e.g. crisis denial), maximizing risk (e.g. moral panic), minimizing intervention effectiveness (e.g. anti-medicine, anti-government) and maximizing effectiveness (e.g. drug lobbyism). We discuss common cognitive biases, including normalcy bias, ostrich effect, negativity bias, Just World Fallacy, false consensus effect, action bias and death spiral effect. Furthermore, we present an overview of potential debiasing processes and tools. Debiasing may help enhance the quality of implementations and trust in institutions, to the benefit of both science and society at large.</p>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":" ","pages":"e70064"},"PeriodicalIF":4.4000,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Investigation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/eci.70064","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Policy decision-making should use the best evidence obtained with the most rigorous and reproducible science and should be applied with minimal bias to maximize positive outcomes. This is particularly important in public health and other major decisions. Reality, however, is usually far from this ideal. The quality and use of scientific evidence to address wicked problems and sticky crises have been the focus of intense debate. Policymakers often succumb to fallacies, leading to suboptimal decision-making and maladaptive practices. We map the key biases involved at three different, but communicating, domains: the scientific evidence itself, the policymakers and the citizens. Biases may be classified along two axes pertaining to the perception of the risk and the perception of the effectiveness of the intervention: minimizing risk (e.g. crisis denial), maximizing risk (e.g. moral panic), minimizing intervention effectiveness (e.g. anti-medicine, anti-government) and maximizing effectiveness (e.g. drug lobbyism). We discuss common cognitive biases, including normalcy bias, ostrich effect, negativity bias, Just World Fallacy, false consensus effect, action bias and death spiral effect. Furthermore, we present an overview of potential debiasing processes and tools. Debiasing may help enhance the quality of implementations and trust in institutions, to the benefit of both science and society at large.
期刊介绍:
EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.